See what a drug will do to this patient’s proteins — before the visit, not after the side effects.
The Navi8 Clinician Dashboard is the same review surface a household manager uses, pointed at your patient panel: adherence, symptoms and reconciliation on one timeline, a visit-prep pack that writes itself from patient logs, and a new capability nobody else offers — high-throughput scenario testing of a treatment plan on the PHT-CSEIRA pipeline.
The context pack is ready before you open the door.
Reports increased morning stiffness, fatigue and intermittent migraine. Nausea contributed to skipped methotrexate doses.
Two missed weekly methotrexate doses; turmeric added May 12; CRP uploaded May 25, up from baseline.
RA flare likely related to adherence gap and stress/sleep disruption. Reconciliation needed before plan change.
Review nausea mitigation, confirm turmeric/NSAID use, compare CRP with symptom timeline, reinforce weekly routine.
| Methotrexate15 mg · weekly | Needs reconciliation |
| Folic acid1 mg · daily | Active |
| Sumatriptan50 mg · as needed | Active |
| Turmeric1,000 mg · daily · supplement | Review |
| Iron bisglycinate25 mg · daily · supplement | Logged |
One panel, every household. The parts of care that happen between visits, finally visible.
Patient & household management
Your panel is a list of households, not isolated charts. Adherence, symptoms and review flags for every linked member, on the same 30-day range the family sees.
Communication
Secure messages tied to a medication or a flag, so “did you take it?” becomes a one-tap answer with a timestamp — and the answer lands in the record.
Scheduling
Visits, labs and follow-ups on the same calendar the patient already uses for doses — with the visit-prep pack generated automatically when the appointment is set.
Visit prep & SOAP drafting
Subjective, objective, assessment and plan drafted from patient logs, reconciled medications and uploaded labs. You edit; the draft never leaves your session without you.
Test the plan against the patient before you write it.
Propose a treatment plan — a new agent, a dose change, an added medication — and Navi8 screens it against the patient’s own protein panel: same-class alternatives ranked by structural fit, off-target risk signals, and interaction hypotheses with everything else on the list. In minutes, with provenance on every result.
- Alternatives — same-class and repurposed candidates that bind the patient’s variant, not the reference.
- Side-effect risk — structural signals across an off-target safety panel, rank-ordered within class.
- Interactions — prioritized pairs from the full medication list, tested for affinity shift and site overlap.
- Evidence alongside — drug-class and documented-interaction evidence shown separately from the structural signal, always.
Research and decision-support only. Structural signals are not adverse-event probabilities; Navi8 does not diagnose or prescribe.
Ranked same-class candidates against the patient’s panel, with pose and interface confidence.
Documented NSAID–methotrexate interaction class evidence, sourced and versioned.
Why each protein is on the panel — a carried variant, a target, or a class-wide safety check.
Two pilot sites are running. We are opening a third.
Clinician-first validation, with physician and patient feedback already reshaping the product. A third site gives a comparative read-out across independent panels — the evidence a payer asks for before a population contract.
- Small panel, defined cohort, 6–12 month read-out.
- Dashboard, household surface and scenario testing included.
- Published results, co-authored with the site.